Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.  

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.  

Save Category as RSS Feed
Search results for "". Page 1 of 1, Results 1 to 8
Title Location Sort descending Country
Reset
Attaché.e scientifique médical, Psychiatrie (Ontario)
Attaché.e scientifique médical, Psychiatrie (Ontario) Toronto, Quebec, CA Sep 23, 2022 0.00 mi
Toronto, Quebec, CA Canada
Medical Science Liaison, Psychiatry (Ontario)
Medical Science Liaison, Psychiatry (Ontario) Toronto, Quebec, CA Sep 23, 2022 0.00 mi
Toronto, Quebec, CA Canada
Director Global Regulatory Affairs CMC Biologics - Remote Opportunity
Director Global Regulatory Affairs CMC Biologics - Remote Opportunity Seattle, Washington, US Sep 21, 2022 0.00 mi
Seattle, Washington, US United States
Attaché.e scientifique médical.e, neurologie (Québec et Maritimes) Montreal, Quebec, CA Canada
Medical Science Liaison, Neurology (Quebec/Maritimes)
Medical Science Liaison, Neurology (Quebec/Maritimes) Montreal, Quebec, CA Sep 1, 2022 0.00 mi
Montreal, Quebec, CA Canada
Regulatory Strategy Lead
Regulatory Strategy Lead Copenhagen, Hovedstaden, DK Aug 31, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark
CMC Project Director
CMC Project Director Copenhagen, Hovedstaden, DK Sep 20, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark
Senior Data Engineer
Senior Data Engineer Copenhagen, Hovedstaden, DK Sep 15, 2022 0.00 mi
Copenhagen, Hovedstaden, DK Denmark